Make your products visible globally with Elite Membership.
I agree to the terms and conditions
Existing User?
Sign In with Email
Remember Me Forgot Password?
New User?
Enter your registered Email ID to get reset password.
Elite Member
Individual Register
BASEL, SWITZERLAND/SAN DIEGO, US: Sorrento Therapeutics Inc and Lonza will sign a non-exclusive research license agreement, for access to Lonza’s GS Xceed Gene Expression System. The GS Xceed System will be used in the generation of stable expression cell lines for the production and development of therapeutic antibodies in Sorrento’s product portfolio.
The research license agreement will give Sorrento access to Lonza’s GS technology for use in Sorrento’s maturing pipeline of therapeutic antibodies in oncology, inflammation, and infectious disease.
“We are excited to license Lonza’s GS Xceed System for the development of our lead human therapeutic antibody programme. The speed and ease of use of the GS Xceed System will aid in the rapid selection of high-producing cell lines and accelerate the production and development of our most promising therapeutic candidates,” said Henry Ji, PhD, President and CEO, Sorrento Therapeutics.
© Worldofchemicals News
Login
ZUG, SWITZERLAND: Foster Wheeler’s Global Engineering and Construction subsidiary has been awarded a concept study by Western Cluster Limited (W ...
LONDON, UK: Mark Post, Professor, Maastricht University has revealed a cultured beef burger at an event in London. As the world’s population gro ...
PLYMOUTH, US: The Mosaic Company has entered into a shareholders’ agreement with Saudi Arabian Mining Company (Ma’aden) and Saudi Basic In ...
TOKYO, JAPAN: Asahi Glass Co Ltd (AGC) will invest approximately ¥40 billion ($406 million) to significantly increase the production capacity of i ...
ZUG, SWITZERLAND: The Global Engineering and Construction Group subsidiary of Foster Wheeler AG has been awarded an engineering, procurement and const ...
COLUMBUS, US: Momentive Specialty Chemicals Inc (MSC) and MicroBlend Inc have formed a new joint venture company located in Cali, Colombia. The new co ...
Stay updated with the latest chemical industry trends and innovations.
Verification Code has been sent to
Please enter the Verification Code below to verify your Email Address.If you cannot see the email from "noreply@worldofchemicals.com" in your inbox,make sure to check your SPAM Folder